Laurène Peckeu

Doxycycline in Creutzfeldt-Jakob disease: a phase 2, randomised, double-blind, placebo-controlled trial

Gabriella Marcon, Alain Mallet, Mauro Tettamanti et al. · The Lancet Neurology · 2014 · 200 citations

Creutzfeldt-jakob Disease, Medicine, Placebo-controlled Trial +4

Neuropathology of iatrogenic Creutzfeldt–Jakob disease and immunoassay of French cadaver-sourced growth hormone batches suggest possible transmission of tauopathy and long incubation periods for the transmission of Abeta pathology

Charles Duyckaerts, Véronique Sazdovitch, Kunié Ando et al. · Acta Neuropathologica · 2017 · 78 citations

Neurodegenerative Diseases, Iatrogenic Creutzfeldt–jakob Disease, Autoimmune Disease +10

Accuracy of diagnosis criteria in patients with suspected diagnosis of sporadic Creutzfeldt-Jakob disease and detection of 14-3-3 protein, France, 1992 to 2009

Laurène Peckeu, N. Delasnerie–Lauprêtre, Jean‐Philippe Brandel et al. · Eurosurveillance · 2017 · 33 citations · Full text

Sporadic Creutzfeldt-jakob Disease, Creutzfeldt-jakob Disease, Neurological Disorder +16

Impact and effectiveness of the 10-valent pneumococcal conjugate vaccine on invasive pneumococcal disease among children under 5 years of age in the Netherlands

Laurène Peckeu, Arie van der Ende, Hester E. de Melker et al. · Vaccine · 2020 · 25 citations · Full text

Reducing contacts to stop SARS-CoV-2 transmission during the second pandemic wave in Brussels, Belgium, August to November 2020

Brecht Ingelbeen, Laurène Peckeu, Marie Laga et al. · Eurosurveillance · 2021 · 16 citations · Full text

November 2020, Contact Tracing, Covid-19 Pandemic +11